Vnitr Lek 1996, 42(2):93-97
[Pharmacodynamics of angiotensin-converting enzyme inhibitors].
- Klinika farmakoterapie, Ustav preventívnej a klinickej medicíny, Bratislava.
ACEI form a group of antihypertensives which inhibit the angiotensin II (A II) production and thus not only reduce the blood pressure but exert also a positive metabolic and antiproliferative effect (A II is a proliferative hormone). They are therefore indicated nowadays in the treatment of essential and secondary hypertension, left-ventricular hypertrophy, chronic heart failure, acute myocardial infarction, insulin resistance and other disorders. Despite intensive studies we still do not know many, in particular mediated effects, of ACEI but these drugs have become one of the key groups in therapy.
Keywords: Angiotensin-Converting Enzyme Inhibitors, pharmacology, ; Blood Pressure, drug effects, ; Heart, drug effects, ; Humans; Kidney, drug effects, ; Renin-Angiotensin System, drug effects,
Published: February 1, 1996 Show citation